Create Free Account

By creating account you will get access to hot stocks & personalised emails

Blue-Chip

Two Growth Stock Picks - Ramsay Health Care + G8 Education

October 25, 2015 | Team Kalkine
Two Growth Stock Picks - Ramsay Health Care + G8 Education

Ramsay Health Care Ltd



Expanding market opportunity would drive its domestic and International business: Ramsay Health Care Limited (ASX: RHC) delivered a solid revenue increase by 49.8% year over year (yoy) to $7.4 billion in FY15, with its Australian and Asian business rising by 8.2% yoy to $4,055.5 million in fiscal year of 2015. RHC has already built a strong network of 226 hospitals, with 115 in France, 36 in United Kingdom, 3 in Malaysia, 3 in Indonesia and 69 in Australia. We believe that the group would continue to enhance its business, as it is well positioned to leverage the growing demand for health care driven by rising ageing demographics in Australia and continue to expand its capacity through its brownfield investment strategy. RHS had already finished developing capacities worth of $190 million during fiscal year of 2015 which comprised over $58.2 million expansion related to Warringal Private in Heidelberg, Melbourne; $53.3 million worth of expansion at Pindara Private on the Gold Coast as well as the $19.5 million expansion of Kareena Private in Sydney. The group also approved over $197 million for building new brownfields capacity along with existing projects. RHS is also expanding its presence in China, Indonesia, Malaysia and France apart from Australia. Accordingly, Ramsay made an agreement with Jinxin, a Chinese based health care company, to jointly operate five hospitals in the city of Chengdu, China during this year. Synergies from two hospitals integration - Ramsay Santé and Générale de Santé in the coming months would also boost its France business. Impact from the Australian government’s review of the Medical Benefits Scheme on examining the merits of 5,700 subsidized items, on RHC is yet to be seen.
 

Financial performance (Source: Company Reports)

Ramsay healthcare shares delivered a year to date returns of over 4% (as of October 23, 2015), and we believe that the stock is poised to grow in the coming months. Based on the foregoing, we give a “BUY” recommendation to the stock at the current price of $60.200.


RHC Daily Chart (Source: Thomson Reuters)

G8 Education Ltd


 
Affinity takeover battle: G8 Education Ltd (ASX: GEM) had approached Affinity for a potential takeover, to strengthen its Australian childcare centers, but Affinity declined GEM’s offer. Moreover, the takeover panel had recently ordered GEM that affinity shares acquired from Taxonomy Pty Ltd in excess of 20% of the total voting power in Affinity, need to be disposed by GEM and also issued withdrawal rights to non-associated Affinity shareholders who accepted GEM’s bid. Meanwhile, Affinity Education agreed the terms of Anchorage Capital which bid for 92 cents per Affinity security, against the GEM’s recent cash offer of 80 cents for each Affinity share. The shares of GEM plunged over 28.87% (as of October 23, 2015) during this year to date partly impacted by the investor’s concerns on its dependence on acquisitions for growth as well as Affinity takeover battle. On the other hand, G8 Education Ltd built a strong network of 457 centers in Australia and 18 centers in Singapore, after adding 21 new centers in first half of FY2015. GEM need to settle 17 more centers, and after this GEM expects to have 35,125 licensed places in Australia. G8 Education also delivered solid performance with a 5.6% yoy revenue growth (for its 229 centers-Like for Like growth) during the first half of fiscal 2015, while its underlying EPS soared 60% on year over year (yoy) basis during the same period, indicating its capabilities of deriving synergies through acquisitions.


Financial Performance (Source: Company Reports)

Moreover, around $3.5 billion worth of government’s federal budget was allotted to childcare, which might benefit GEM’s centers and subsequently drive the group’s price per child revenue, if more parents start working. GEM also has an outstanding dividend yield of over 7.9%. We reiterate our “BUY” recommendation on the stock at the current price of $3.03.


GEM Daily Chart (Source: Thomson Reuters)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people.Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation.Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product.The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
Copyright
Copyright © 2015 Kalkine Pty Ltd ABN 34 154 808 312. No part of this website, or its content, may be reproduced in any form without the prior consent of Kalkine Pty Ltd.
Kalkine is a trading name of Kalkine Pty Ltd ABN 34 154 808 312, which holds Australian Financial Services Licence No. 425376.
Small-Cap
One Energy Stock Focused on Strengthening Asset Reliability and Driving Organic Growth -KAR
November 26, 2024Team Kalkine
Mid-Cap
Technical Analysis on One ASX-Listed Stock – CIA
November 25, 2024Team Kalkine
Blue-Chip
Key Business Insights on this Consumer Staples Company– TGT
November 25, 2024Team Kalkine
Small-Cap
One NASDAQ- Listed Movies & Entertainment ADR Under Radar- iQIYI, Inc
November 22, 2024Team Kalkine
Blue-Chip
One Internet Services & Infrastructure Stock Near Resistance Levels – SNOW
November 22, 2024Team Kalkine

Get In Touch

By submitting your details and clicking on the Register button below, you agree to Kalkine’s Terms and Conditions and agree to receive marketing offers, including to be contacted by email or phone, as set out in our Privacy Policy. Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf.You also agree that Kalkine/KSPL can give you its Financial Services Guide by electronic means (including by website link or email). Before accessing our services, please read the Financial Services Guide available here.

Please wait processing your request...

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.